UK Markets open in 5 hrs

Global PCR Market Outlook 2022-2025 - New Levels of Sensitivity have Implications for Liquid Biopsy and Cancer Screening Markets

·4-min read

Dublin, Jan. 05, 2022 (GLOBE NEWSWIRE) -- The "Global PCR Market Outlook 2021-2025: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets; by Application, Product & Place; with Executive & Consultant Guides, Including Customized Forecasting & Analysis - Updated to Include Impact of COVID-19 Dx" report has been added to ResearchAndMarkets.com's offering.

The report forecasts the market size out to 2025 with the only analysis available that breaks out Singleplex and Multiplex testing markets.

Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.

COVID-19 Diagnostics is driving PCR into a dominant technology role and spurring the growth of new PCR based technologies.

Will thermal cycling become obsolete? Are singleplex tests going to be obsolete? Will routine respiratory screening become a reality? Will diagnostics move into the Physician's Office or even the Home? Will digital PCR become the new lab standard?

PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. Driven even faster by the huge demand for pandemic diagnostics.

New levels of sensitivity have implications for Liquid Biopsy and Cancer Screening markets. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance.

Players in a Dynamic Market

  • Academic Research Lab

  • Diagnostic Test Developer

  • Genomic Instrumentation Supplier

  • Cell Separation and Viewing Instrumentation Supplier

  • Pharmaceutical/Reagent Supplier

  • Independent Testing Lab

  • Public National/regional lab

  • Hospital lab

  • Physician Lab

  • Audit Body

  • Certification Body

Market Trends

Factors Driving Growth

  • A New Standard

  • Down the Curve We Go

  • Multiplexing

  • Syndromic Diagnostics Looks Unstoppable

  • The Genetic Blizzard

Factors Limiting Growth

  • The Cost Curve

  • The Other Guys

  • Systemic Roadblocks

Diagnostic Technology Development

  • The Instrumentation Curve

  • Shifting Role of Diagnostics

  • Diagnostics Moves Out of the Hospital

  • Disruption Looms

  • The Next Five Years

PCR Recent Developments

  • Chelex-Based Protocol to Reduce Cost, Time for PCR Testing

  • Finnish Firms to Form Point-of-Care Testing Firm

  • Visby Medical Scales Up Handheld PCR Test for STIs

  • DnaNudge Raises $60M

  • Roche Reports Diagnostics Revenue Up 51 Percent

  • BforCure Preparing Multiple ID Panels for PoC qPCR Platform

  • Enzo Biochem, CLX Health Partner for C19 Testing for Travel

  • Bio Molecular Systems Gets Approval for Portable PCR Cycler

  • Roche Acquires GenMark

  • Handheld qPCR Devices Close to Commercialization

  • Nuclein Closes $14M in Funding

  • WuXi Diagnostics Closes $150M Series B Financing Round

  • Visby Medical to develop rapid Flu-COVID PCR test

  • Thermo Fisher to acquire Mesa Biotech

  • Scope Fluidics Secures €6.2M Supporting Rapid MDx

  • SARS- Testing Demand to Continue 'Through 2022, and Beyond'

  • Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection

  • Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR

  • Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition

  • HelixBind Receives $3M NIH Grant to Expand Infection Dx Platform

  • Nucleix Targeting US Market With Bladder, Lung Cancer Assays

  • DxTerity Gets CE Mark for At-Home Sample Collection Device

  • Fetal Cell-Based NIPT by dDigital PCR Demonstrated

  • ChromaCode Raises $28M for new High Def PCR Technology

  • ddPCR Used for Fast and Low-Cost NIPT Screening

  • Study Validates ChromaCode HDPCRT Testing for Tick-Borne Pathogens

  • Bio-Rad's ddPCR MSI RUO Assay is available

  • ctDNA Monitoring Is Important for BRAF-Mutant Melanoma

  • Sysmex Inostics Liquid Biopsy Demonstrates Two-fold Higher Detection

  • QIAGEN Plans for Next-Generation Digital PCR Systems

  • Bioneer HIV-1 Dx Kit Gets Korea FDA Approval

  • New PCR Technology: Transfer-PCR (tPCR) Applications

  • NimaGen Licenses PCR Tech from Salisbury NHS Foundation Trust

  • Natera Applies Massively Multiplexed PCR to Kidney Transplants

  • Paragon Genomics, MGI Tech Form Distribution Alliance

Profiles of Key PCR Companies

  • Abacus Diagnostica

  • Abbott Diagnostics

  • Accelerate Diagnostics

  • Ador Diagnostics

  • Agilent

  • Akonni Biosystems

  • Alveo Technologies

  • Applied BioCode

  • Aus Diagnostics

  • Beckman Coulter Diagnostics

  • Becton, Dickinson and Company

  • Binx Health

  • Biocartis

  • bioMerieux Diagnostics

  • Bioneer Corporation

  • Bio-Rad Laboratories, Inc

  • Bosch Healthcare Solutions GmbH

  • Bruker

  • Caris Molecular Diagnostics

  • Cepheid (now Danaher)

  • Credo Diagnostics Biomedical

  • Cue Health

  • Curetis N.V. / Curetis GmbH

  • Diagenode Diagnostics

  • Diasorin S.p.A.

  • Enzo Life Sciences, Inc.

  • Eurofins Scientific

  • Fluidigm Corp

  • Fluxergy

  • Fusion Genomics

  • Genetic Signatures

  • GenMark Dx

  • Hibergene Diagnostics

  • Hologic

  • Immunexpress

  • Inflammatix

  • Invetech

  • Janssen Diagnostics

  • Karius

  • Lexagene

  • LightDeck Diagnostics

  • Luminex Corp

  • Maxim Biomedical

  • Mbio Diagnostics

  • Meridian Bioscience

  • Mesa Biotech

  • Millipore Sigma

  • MIODx

  • Mobidiag

  • Nanomix

  • NGeneBio

  • Operon

  • Panagene

  • Perkin Elmer

  • Precipio

  • Primerdesign

  • Promega

  • Prominex

  • Qiagen Gmbh

  • Quantumdx

  • Quidel

  • Roche Molecular Diagnostics

  • Saw Diagnostics

  • Seegene

  • Siemens Healthineers

  • SkylineDx

  • Sona Nanotech

  • SpeeDx

  • T2 Biosystems

  • Thermo Fisher Scientific Inc.

  • Veramarx

  • Visby Medical

  • XCR Diagnostics

For more information about this report visit https://www.researchandmarkets.com/r/w78y2g

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting